Carlos
Luri Rey
Personal Investigador en Formación
Yale School of Medicine
New Haven, Estados UnidosPublications in collaboration with researchers from Yale School of Medicine (1)
2022
-
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Journal for immunotherapy of cancer, Vol. 10, Núm. 3